10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Antimicrobial therapy plays a pivotal role in combating infectious diseases, employing agents that target and eliminate microorganisms. Antibiotics, a subset of antimicrobials, are widely used to treat bacterial infections. They work by inhibiting bacterial growth or destroying the bacteria, offering effective solutions for a range of illnesses. However, overuse and misuse of antibiotics contribute to the emergence of drug-resistant strains, underscoring the need for judicious antibiotic stewardship. Antiviral drugs are designed to combat viral infections by inhibiting viral replication or entry into host cells. Antifungal agents target fungal pathogens, addressing conditions like candidiasis or aspergillosis. The continuous development of new antimicrobial therapies remains essential to stay ahead of evolving resistance patterns, ensuring effective treatment options for infectious diseases.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : An unprecedented West Nile virus outbreak in Israel (2024): A textbook case for the One Health approach
Michel Bellaiche, Kimron Veterinary Institute, Israel
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, IDFISH Technology, United States
Title : Candida auris infections are global health challenge
Reza Nassiri, Michigan State University, United States
Title : Host brakes on viral inflammation
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States